| ||||||||||||||
|
|
|||||||||||||
Department of Anaesthesia and Intensive Care; Chinese University of Hong Kong; Prince of Wales Hospital; Shatin, Hong Kong; mtvchan{at}cuhk.edu.hk
To the Editor:
Liu et al. (1) reported a decrease in bispectral index (BIS) after a bolus dose of atracurium in patients receiving target-controlled infusion (TCI) of propofol. We believe their observations are confounded because the effect-site propofol concentrations were not at steady-state when the measurements were recorded. This is demonstrated by the significant decrease in BIS readings in the saline control group, suggesting model mis-specification of the TCI pump. The study's conclusions would have been more definitive if a few minutes of equilibration had been allowed before the injection of atracurium.
We recently reported the performance of BIS during electrocautery (2). In this experiment we also recorded BIS measurements before and after administering muscle relaxant. Forty-five patients undergoing elective surgery received TCI of propofol and remifentanil, with target effect-site concentrations of 3 µg/mL and 4 ng/mL, respectively. After steady-state conditions were achieved, all patients received an IV bolus dose of rocuronium 0.9 mg/kg. Figure 1 shows the BIS readings and electromyographic (EMG) power 1 min before and 3 min after patients received this dose. The mean (±sd) BIS readings before rocuronium 56.4 ± 6.7 were similar to those after rocuronium 57.0 ± 5.7 paired Student's t-test, P = 0.40. Similarly, there was no significant change in EMG activity over the forehead (P = 0.60). The signal-quality index was above 95 throughout the measurements. Our data are consistent with previous reports that demonstrated that neuromuscular blockade did not affect BIS monitoring in anesthetized patients (3,4).
|
REFERENCES
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|